Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PGEN | Common Stock | Options Exercise | +35.9K | +42.22% | 121K | Mar 24, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PGEN | Restricted Stock Units | Award | $0 | +108K | $0.00 | 108K | Mar 24, 2023 | Common Stock | 108K | Direct | F1, F2 | ||
transaction | PGEN | Restricted Stock Units | Options Exercise | $0 | -35.9K | -33.33% | $0.00 | 71.7K | Mar 24, 2023 | Common Stock | 35.9K | Direct | F1, F3 | |
transaction | PGEN | Option to Purchase Common Stock (Right to Buy) | Award | $0 | +46.8K | $0.00 | 46.8K | Mar 24, 2023 | Common Stock | 46.8K | $0.96 | Direct |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
F2 | 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. |
F3 | Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. |